Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inception 3 Inc.

Latest From Inception 3 Inc.

Here To Stay: Inception Sciences Shows Why Build-To-Buy Works

Born at a time when venture capital found few exit opportunities for early-stage companies, build-to-buy helped mitigate the risk in investing in uncharted science. But the model is flourishing even in this period of wider capital options.

BioPharmaceutical Strategy

“Build-To-Buy” Startup Model Alive And Kicking, Invested Execs Say

VCs and big pharma execs, speaking at CALBIO, said that even in today’s freer economic climate, investing early in startups, with an option to buy when the time is right, is still a viable business strategy.

Strategy Deals

Start-Up Quarterly Statistics, Q2 2014

Start-ups raised $893.9 million in Q2 2014, a 25% drop from last quarter’s record-setting $1.18 billion. Metabolic disease was the most prevalent therapeutic category involved in alliances; seven acquisitions were signed, five in the biopharma sector.

BioPharmaceutical Medical Device

With Two New Deals, Versant Ventures Enlists More Pharma Partners To Share Biotech Risk

Versant is betting a sizable amount of its portfolio on drug assets, instead of full-blown companies, with single buyers holding options to acquire each one.

BioPharmaceutical Canada
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Otolaryngology
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Inception 3 Inc.
  • Senior Management
  • Peppi Prasit, PhD, CEO
  • Contact Info
  • Inception 3 Inc.
    Phone: (858) 224-7700
    5871 Oberlin Dr.
    Ste. 100
    San Diego, CA 92121
    USA
UsernamePublicRestriction

Register